Advent Pharma Limited announced earnings results for the second quarter ended December 31, 2018. For the second quarter, the company announced sales was BDT 174.428 million compared to BDT 89.253 million a year ago. Operating income was BDT 66.952 million compared to BDT 26.092 million a year ago. Net income was BDT 47.461 million compared to BDT 15.303 million a year ago. Basic earnings per share was BDT 0.63 compared to BDT 0.28 a year ago. For the half year, sales was BDT 329.907 million compared to BDT 184.880 million a year ago. Operating income was BDT 126.949 million compared to BDT 53.501 million a year ago. Net income was BDT 89.092 million compared to BDT 31.652 million a year ago. Basic earnings per share was BDT 1.18 compared to BDT 0.57 a year ago.